STABLECOIN DEVELOPMENT CORPORATION Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2015-11-19: Form 8-K; Exhibit 10.1; Description Separation Agreement, dated November 18, 2015.
- 2015-08-13: Form 10-Q; Exhibit 10.2; Description Securities Purchase Agreement dated May 18, 2015, by and between NovaBay Pharmaceuticals, Inc. and the investors named therein..
- 2015-08-13: Form 10-Q; Exhibit 10.1; Description Securities Purchase Agreement, dated May 18, 2015, by and between NovaBay Pharmaceuticals, Inc. and the investors named therein..
- 2015-03-26: Form 10-K; Exhibit 10.29; Description Agreement by and between NovaBay Pharmaceuticals, Inc. and Naqu Area Pioneer Pharma Co. Ltd., dated December 30, 2014..
| Filed | Form | Exhibit | Description |
|---|
| 2015-11-19 | 8-K | 10.1 | Separation Agreement, dated November 18, 2015 |
|---|
| 2015-08-13 | 10-Q | 10.2 | Securities Purchase Agreement dated May 18, 2015, by and between NovaBay Pharmaceuticals, Inc. and the investors named therein. |
|---|
| 2015-08-13 | 10-Q | 10.1 | Securities Purchase Agreement, dated May 18, 2015, by and between NovaBay Pharmaceuticals, Inc. and the investors named therein. |
|---|
| 2015-03-26 | 10-K | 10.29 | Agreement by and between NovaBay Pharmaceuticals, Inc. and Naqu Area Pioneer Pharma Co. Ltd., dated December 30, 2014. |
|---|
| 2015-03-26 | 10-K | 10.28 | Assignment and Assumption Agreement by and among NovaBay Pharmaceuticals, Inc. and Pioneer Pharma Co. Ltd., dated January 2, 2013. |
|---|
| 2015-03-09 | 8-K | 10.2 | Form of Registration Rights Agreement, dated March 6, 2015, between NovaBay Pharmaceuticals, Inc. and the purchasers identified on Schedule I of the Securities Purchase Agreement, dated March 3, 2015. |
|---|
| 2015-03-09 | 8-K | 10.1 | Form of Securities Purchase Agreement, dated March 3, 2015, between NovaBay Pharmaceuticals, Inc. and the purchasers identified on Schedule I thereto. |
|---|